The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Byrnes Michael since 2014.
This trader's CIK number is 1619893.
At the time of last reporting, Byrnes Michael was the Chief Financial Officer of Effector Therapeutics, Inc.. (stock ticker symbol EFTR).
Also see all insider trading activities at Effector Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | EFTR | 25,000 | $33,275 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | OCRX | 3,000 | $3,854 | 0 | $0 | 0 | $0 |
| 2016 | OCRX | 3,500 | $7,244 | 0 | $0 | 0 | $0 |
| 2015 | OCRX | 2,500 | $9,025 | 0 | $0 | 0 | $0 |
| 2014 | OCRX | 2,000 | $9,620 | 0 | $0 | 0 | $0 |
1. Effector Therapeutics, Inc. (EFTR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-06-07 | EFTR | Buy | 25,000 | 1.33 | 33,275 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-03-28 | OCRX | Buy | 3,000 | 1.28 | 3,854 |
| 2016-01-15 | OCRX | Buy | 3,500 | 2.07 | 7,244 |
| 2015-05-06 | OCRX | Buy | 2,500 | 3.61 | 9,025 |
| 2014-10-01 | OCRX | Buy | 2,000 | 4.81 | 9,620 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Byrnes Michael (Chief Financial Officer of Effector Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.